# ALTEROLA BIOTECH INC.

ALTEROLA BIOTECH INC. is a company headquartered in Birkenhead Merseyside, United Kingdom.

## Company overview

- **Legal name:** ALTEROLA BIOTECH INC.
- **Former names in filing history:** JEDEDIAH RESOURCES CORP. (2008-12-12 to 2010-11-19)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Birkenhead Merseyside, United Kingdom
- **Fiscal year end:** March 31
- **SEC CIK:** 0001442999

## About

ALTEROLA BIOTECH INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001442999, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2024-07-18, it reported net income of USD -2,374,379; total assets of USD 3,663 for the fiscal period ended 2024-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-03-31)

- **Net income:** -$2.4M (USD -2,374,379)
- **Total assets:** $3,663 (USD 3,663)
- **Operating cash flow:** -$1.4M (USD -1,447,088)

### FY2023 (period ended 2023-03-31)

- **Net income:** -$1.7M (USD -1,742,457)
- **Total assets:** $12.4M (USD 12,376,963)
- **Operating cash flow:** -$1.0M (USD -1,039,792)
- **Later filings:** Net income, Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-03-31)

- **Net income:** -$6.5M (USD -6,471,134)
- **Total assets:** $12.1M (USD 12,127,961)
- **Operating cash flow:** $44,344 (USD 44,344)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-09-30)

- **Net income:** -$250,511 (USD -250,511)
- **Total assets:** $15,273 (USD 15,273)
- **Cash and equivalents:** $0 (USD 0)
- **Operating cash flow:** $0 (USD 0)

## Recent SEC filings

- Form 8-K — filed 2025-06-30 — period 2025-05-16 — FORM 8-K
- Form 10-Q — filed 2024-11-29 — period 2024-09-30 — FORM 10-Q
- Form 8-K — filed 2024-09-30 — period 2024-09-27 — FORM 8-K
- Form 8-K — filed 2024-09-12 — period 2024-08-30 — FORM 8-K
- Form 10-Q — filed 2024-08-15 — period 2024-06-30 — FORM 10-Q
- Form 10-K — filed 2024-07-18 — period 2024-03-31 — FORM 10-K
- Form 10-Q — filed 2024-02-20 — period 2023-12-31
- Form 10-Q — filed 2023-11-21 — period 2023-09-30
- Form 8-K — filed 2023-10-20 — period 2023-10-16
- Form 8-K — filed 2023-10-17 — period 2023-10-10
- Form 8-K — filed 2023-09-19 — period 2023-09-08
- Form 10-Q — filed 2023-08-15 — period 2023-06-30

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/alterola-biotech-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology